how long has tirzepatide been on the market Tirzepatide, active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, more tricks up its sleeve. Research out this week shows that it can do wonders Tirzepatide (Zepbound) for weight loss

A federal judge dismissed the case in November 2025, ruling the company did not show the groups held monopoly power over the competition

Operating through mimicking the GLP-1 hormone, it reduces appetite and supports sustained weight loss

I took the chance, and it has by far exceeded my expectations

The program operates separately from the usual Part D coverage and payment system and is scheduled to run through December 31, 2027, according to the Centers for Medicare & Medicaid Services

Additionally, it is approved for use in obesity treatment, making it an invaluable tool in the battle against excess body weight

The most effective approach is a vet-guided plan combining calorie reduction, daily exercise, and targeted supplements